Figure 2.
Model depicting the pathway induced by PTH (1–34), PTHrP (1–36), and abaloparatide (ABL), which leads to RANKL upregulation. Reprinted from [27]. Distributed under the terms of the Creative Commons Attribution licence (CC BY 4.0).
Model depicting the pathway induced by PTH (1–34), PTHrP (1–36), and abaloparatide (ABL), which leads to RANKL upregulation. Reprinted from [27]. Distributed under the terms of the Creative Commons Attribution licence (CC BY 4.0).